6550--Immuno Mycology BPA
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically the Lexington VAMC, has issued a Justification and Approval (J&A) for a sole source firm fixed-priced Blanket Purchase Agreement (BPA) with Immuno Mycologies Inc. for fungal complement fixation and immunodiffusion testing services. This acquisition, valued at $656,708.82 over five years, is deemed crucial for Veteran care.
Scope of Work
The requirement is for fungal complement fixation testing (CFT) and immunodiffusion (ID) reagents and positive controls. These are essential for detecting antibodies in patient serum to aid in the diagnosis of four specific fungal diseases: Histoplasmosis, Blastomycosis, Coccidioidomycosis, and Aspergillosis. The Lexington VAMC Special Reference Laboratory performs these tests for Veterans across the nation.
Contract Details
- Contract Type: Sole Source Firm Fixed-Price Blanket Purchase Agreement (BPA)
- Awardee: Immuno Mycologies Inc., 2701 Corporate Centre Dr., Norman, OK 73069
- Total Value: $656,708.82
- Period of Performance: February 19, 2026, to February 18, 2031 (five ordering periods)
- Contracting Office: Department of Veterans Affairs, NCO 9, Lexington VAMC
- Product Service Code: 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits And Sets)
Justification for Sole Source
The statutory authority cited for this Other Than Full and Open Competition is 41 USC §3304(a)(1) - Only One Responsible Source. The VA determined that the required testing reagents are exclusively manufactured and supplied by the Original Equipment Manufacturer (OEM), Immuno Mycologies Inc. Market research conducted using SAM, DSBS, and FPDS databases confirmed that no other sources could meet this specific requirement. The acquisition is being made using simplified acquisition procedures, and no sources notices will be issued.
Future Competition
The agency plans to conduct market research for future procurements to determine if barriers to competition can be overcome for subsequent acquisitions of these services.
Contact Information
For inquiries, contact Darrell Wright, Contract Specialist, at darrell.wright@va.gov or 615-225-5974.